Gossamer Bio Inc (GOSS) Stock Analysis

Gossamer Bio Inc (GOSS) is a publicly traded company in the HEALTHCARE sector. It trades at $0.20, carries a market capitalization of $46.49M. This page summarizes the public market data, fundamentals, and frequently asked questions for GOSS, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Gossamer Bio Inc currently has a Bearish sentiment score of -0.50.

About Gossamer Bio Inc

Gossamer Bio, Inc. is a San Diego-based clinical-stage biopharmaceutical firm focused on the discovery and development of innovative therapies for immunology, inflammation, and oncology. With a robust pipeline that employs advanced scientific insights, Gossamer Bio addresses significant unmet medical needs through its diverse range of drug candidates. As it progresses through clinical trials, the company is committed to providing transformative treatment options for patients with complex dise...

GNG Research Analysis

GNG Research scores Gossamer Bio Inc (GOSS) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for GOSS.

Frequently Asked Questions

Does GOSS pay dividends?

Gossamer Bio Inc (GOSS) does not currently pay a regular dividend.

What is GOSS's market cap?

Gossamer Bio Inc (GOSS) has a market capitalization of $46.49M with a current stock price of $0.20.